Tender Details

Country: Germany
Summary: Conclusion of a Non-exclusive Discount Agreement in Accordance with Section 130a (8) Sgb V for the Active Ingredient Ethosuximide, Atc N03ad01, for the Period December 1, 2020 to November 30, 2022
DET Ref No: 46770449
Deadline: 05 Oct 2022
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: EUR 1.00
Notice Type: Tender
Document Ref. No.: 498041-2020
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Document Type: Contract notice
Title: Conclusion of a non-exclusive discount agreement according to § 130a Paragraph 8 SGB V for the active ingredient ethosuximide, ATC N03AD01, for the period 1.12.2020-30.11.2022
Reference Number: 1003140 - Ethosuximide, ATC N03AD01
Contract Type: Supplies
Estimated Value: 1.00 - EUR
Description: Section 130a (8) of the Social Code Book V enables health insurers and pharmaceutical companies to conclude framework discount agreements on the drugs to be dispensed at the expense of the statutory health insurances. With regard to the relevant legal regulations for the award of public contracts, there is a regular process of active substance-related, formal award procedures according to the regulations of the 4th part of the GWB by DAK-Gesundheit. For medicinal products to be specified by the bidder in Annex 2 to the contract for the above Active ingredient (ethosuximide, ATC N03AD01), DAK-Gesundheit intends to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into effect. A discount agreement i. R. d. Approval model for the above The active ingredient first appears on December 1st, 2020 ...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Conclusion of a Non-exclusive Discount Agreement in Accordance with Section 130a (8) Sgb V for the Active Ingredient Ethosuximide, Atc N03ad01, for the Period December 1, 2020 to November 30, 2022 - Germany Tender

The DAK HEALTH, a Government sector organization in Germany, has announced a new tender for Conclusion of a Non-exclusive Discount Agreement in Accordance with Section 130a (8) Sgb V for the Active Ingredient Ethosuximide, Atc N03ad01, for the Period December 1, 2020 to November 30, 2022. This tender is published on GermanyTenders under DET Ref No: 46770449 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-10-05.

The estimated tender value is EUR 1.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.